Lifecore Biomedical (LFCR) Stock Statistics & Valuation Metrics

Lifecore Biomedical has a market cap or net worth of $178.67M. The enterprise value is $386.59.

Lifecore Biomedical has 37,853,060 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lifecore Biomedical’s return on equity (ROE) is 0.43 and return on invested capital (ROIC) is 1.22%.

The current PE Ratio of Lifecore Biomedical is ―. Lifecore Biomedical’s PEG ratio is 0.51.

In the last 12 months, Lifecore Biomedical had revenue of 34.17M and earned -6.16M in profits. Earnings per share was -0.19.

In the last 12 months, operating cash flow was 3.05M and capital expenditures -3.15M, giving a free cash flow of -106.28K billion.

Lifecore Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Lifecore Biomedical upcoming earnings date is May 12, 2027, After Close (Confirmed).

Lifecore Biomedical as a current ratio of 3.49, with Debt / Equity ratio of 963.57%

In the past 12 months, Lifecore Biomedical has paid 23.00K in taxes.

Lifecore Biomedical EV to EBITDA ratio is 67.68, with an EV/FCF ratio of 69.43.

Lifecore Biomedical has $17.47M in cash and marketable securities with $142.61M in debt, giving a net cash position of -$125.14M billion.

Gross margin is 29.68%, with operating margin of 7.51%, and net profit margin of -18.02%.

The average price target for Lifecore Biomedical is $6.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy